{
  "id": 1556433,
  "title": "Definium Therapeutics Announces New Employee Inducement Grants",
  "url": "https://urgent.news/2026/08/17/definium-therapeutics-announces-new-employee-inducement-grants",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-17T20:05:50.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/definium-therapeutics-announces-new-employee-inducement-grants-12"
  },
  "original_language": "en",
  "account": null,
  "summary": "NEW YORK — Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 32,900 common…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}